The largest database of trusted experimental protocols

28 protocols using tripolyphosphate

1

Chitosan-Oleuropein Nanoparticle Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CONPs were synthesized using a modified ionotropic gelation.37 (link) First, 1 mg/mL chitosan solutions were prepared by dissolving the medium molecular weight CS (50,000–190,000 Da, 75–85% deacetylated, Aladdin Biochemical Technology Co. Ltd, USA) in a solution of hydrochloric acid to 0.04% (v/v). The CS solution was stirred for 1 h and adjusted to pH = 5.5 by NaOH. The oleuropein solutions were prepared by dissolving 0.72 mg oleuropein (Jiangsu Caiwei Biology Science and Technology Co. Ltd, China) in 1mL water. Next, add 1 mL of oleuropein solution to 5 mL of CS solution, stir for a few minutes, and adjust the pH to 5.5. 2 mg/mL tripolyphosphate solution was obtained by dissolving tripolyphosphate (Sigma Aldrich, USA) in distilled water and added dropwise to the CS solution with a volume ratio of 1:5. Finally, the suspensions were stirred for 30 min at room temperature. The concentration of the oleuropein solution used for preparing CONPs was 100 mg/L. Five drops of the suspension were prepared by allowing a single drop of nanoparticle suspension to dry overnight at room temperature on a 200-mesh copper grid. Transmission electron microscope (TEM, HT7700, Hitachi, Japan) was used to observe the morphology of the synthesized nanoparticles (Figure 1).

Transmission electron microscopy (TEM) image of CONPs (scale bar = 100 nm).

+ Open protocol
+ Expand
2

Allopurinol-Loaded Chitosan Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chitosan (80%–85% deacetylation degree, Sigma Aldrich, USA) was dissolved in 0.3 % acetic acid (Glacial, Sigma Aldrich, USA) at 0.6 wt. % concentration at room temperature for 18 h. Then, allopurinol powder (≥ 99% HPLC, Selleckchem, USA) was added to the Chitosan’s solution at 10 % w/w and further stirred for 6 h. Tripolyphosphate (Sigma Aldrich, USA) was dissolved in distilled water at 0.3 wt. % for 4 h. Then, Tripolyphosphate’s solution was added to Chitosan’s solution at 1:3 volume ratios under a strong agitation. The resulting solution was then centrifuged at 15,000 rpm for 45 min. The pellet was harvested and the allopurinol concentration in the supernatant was measured using a spectrophotometer at λ max 338 nm. Encapsulation efficacy was measured using the following equation.
Encapsulation efficacy (%) ═ (1) × 100
The pellet was harvested and lyophilized for 48 h. The produced powder was kept at 4 C until use.
+ Open protocol
+ Expand
3

Fabrication of Chitosan Scaffold Implants

Check if the same lab product or an alternative is used in the 5 most similar protocols

CHIT solution was prepared using a method described
elsewhere (20 (link)). Briefly, we dissolved medium molecular
weight crab shell CHIT (~400 kDa, 85% deacetylated, Sigma-
Aldrich St. Louis, MO, USA) into an aqueous solution (1%
v/v) of glacial acetic acid (Merck, Germany) to a concentration
of 2% (w/v) while stirring on a magnetic stirrer-hot plate. The
solution was stirred with low heat (50˚C) for 3 hours. The
resultant CHIT solution was filtered through Whatman filter
paper after vacuum filtration to remove any un-dissolved
particles. We added glycerol (Sigma Chemical Co., St.
Louis, MO, USA) as 30% (w/w) of the total solid weight in
solution to overcome the fragility of CHIT (21 ). CHIT in
acetic acid (2%, w/v, Merck, Germany) was freeze-dried,
cross-linked with 5% (w/v) tripolyphosphate (Merck
KGaA, Germany), and freeze-dried again to produce a
sponge-like matrix. CHIT scaffolds were prepared at the
dimensions of 4×4×2 mm3 (ca. 5 mg) and implanted at
the transected site (20 (link)).
+ Open protocol
+ Expand
4

Chitosan Scaffolds for Drug Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chitosan
scaffolds were prepared as described with slight modifications to
the protocol.24 (link) Briefly, 1% chitosan gel
was prepared by dissolving chitosan in deionized water containing
1% acetic acid under a continuous stirring condition for 48 h. The
gel was centrifuged at 3350 RCF to pellet-undissolved chitosan flakes,
and a clear supernatant was used for scaffold fabrication. The gel
was aliquoted by weight (750 or 2000 mg) in 5 or 10 mL scintillation
vials, respectively. Rapamycin (1 or 50 μg) or tetracycline
(10 or 100 μg) was added to make drug-loaded scaffolds. The
samples were vortexed thoroughly and frozen at −80 °C
for a minimum of 3 h. The samples were lyophilized for 48 h using
a freeze-dryer (TAITEC, Japan). Sterile crosslinked scaffolds were
prepared by treating the lyophilized gels with 1 mL of sterile 5%
tripolyphosphate (Merck) at pH 5 for 5 min followed by two washes
using sterile 1× PBS.
To determine the swelling characteristics,
tripolyphosphate crosslinked scaffolds were weighed and immersed in
2 mL of 1× PBS and kept at 37 °C. At various times, the
weight of the scaffold was measured after approximately 5 min of drying
to remove excess water. Following weighing, the scaffolds were immersed
in freshly replenished 1× PBS. The change in weight at every
time point was determined by normalizing the value to the original
weight of the scaffold.
+ Open protocol
+ Expand
5

Dodecyl Acetate Extraction and Alginate Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Technical-grade dodecyl acetate (DDA) (97%) was supplied by Merck Life Science S.L. (Madrid, Spain). Its molecular formula and selected properties are as follows: molecular formula, C14H28O2; molecular weight, 228.37 g mol−1; melting point, 150 °C at 15 mmHg; octanol/water partitioning (log Kow), 5.88.
Commercially available bentonite obtained from Merck Life Science S.L. (Madrid, Spain) was used in this study.
The solvent used in the DDA extraction was HPLC-grade hexane obtained from Merck Life Science S.L. (Madrid, Spain). Sodium alginate (medium viscosity, 3.5 kg m−1 s−1 for 2% solution) and tripolyphosphate (90–95%) obtained from Merck Life Science S.L. (Madrid, Spain) and calcium chloride (95%) obtained from Panreac S.A. (Barcelona, Spain) were used in the preparation and evaluation of the CR formulations.
+ Open protocol
+ Expand
6

Polycaprolactone-Chitosan Antimicrobial Scaffold

Check if the same lab product or an alternative is used in the 5 most similar protocols
The materials were purchased as follows: polycaprolactone (PCL) (Sigma–Aldrich, Germany), chitosan (Easter Holding Group, China, MW: 100 KDa, deacetylaton degree: 93%), Cinnamomum zeylanicum (CiZ) essential oil (Zardband Pharmaceutcals Co, Iran), tripolyphosphate (TPP), tween 80, tween 20, Hexafluoro-2-propanol (HFIP), hematoxylin and eosin stain (Merck, Germany), glacial acetic acid and ethanol (> 99.7%, Dr. Mojallali, Iran), and Masson’s trichrome staining kit (Asiapajohesh, Iran).
+ Open protocol
+ Expand
7

Chitosan-TPP Nanoparticle Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols

Chitosan was purchased from Solarbio chemicals (China), Tripolyphosphate (TPP), Acetic acid, Sodium hydroxide (NaOH), and Potassium dihydrogen phosphate from Merck KGaA (Germany). Fresh deionized water was obtained from the Human Ultra-Pure System (Human Corp, Korea).
+ Open protocol
+ Expand
8

Chitosan-based Nanoparticle Encapsulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CAR (5-isopropyl-2-methylphenol CAR, ≥98%), medium molecular weight chitosan (CS) with 85% degree of deacetylation, tripolyphosphate (TPP), bovine serum albumin (BSA) and fluorescein isothiocyanate (FITC) were purchased from Merck, UK. Phosphate buffer saline (PBS) was purchased from Oxoid-Thermo Fisher scientific. Different digestive enzymes e.g. Pepsin (P7000-25G, actual activity: 474 U/mg), pancreatin (P7545, trypsin activity U/mg solid: 6.96) and bile salts (B8631-100G) were provided by Merck life sciences, Germany. Crystal violet dye and Sudan red G were purchased from Daejung Chemicals.
+ Open protocol
+ Expand
9

Chitosan-TPP Nonwoven Fabric Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Medical Grade Chitosan with a medium molecular mass of 198 kDa, deacetylation degree of 76% and insoluble content of < 0.5% was provided by CERTBIO. Tripolyphosphate (TPP) and acetic acid were acquired from Sigma Aldrich and Vetec, respectively; ultrapure water (resistivity of 18.2 MΩ cm) was obtained from a Master System All MS2000—Gehaka System; and nonwoven fabric (NWF) was donated by the MCI Indústria e Comércio de Produtos Eletrônicos Ltda.
+ Open protocol
+ Expand
10

Chitosan-Tripolyphosphate Nanoparticle Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Low molecular weight chitosan (MW < 200 kDa) with a deacetylation degree of 90% and the sodium salt of tripolyphosphate were purchased from Sigma-Aldrich (Saint Louis, MI, USA). Purified feed ingredients were procured from Hi-Media (Hi-Media Laboratories, Mumbai, India). Other chemicals and consumables used in the study were of analytical grade.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!